189 completed, 49 unknown, 26 recruiting, 23 terminated. 82 Not applicable, 31 Phase 1, 30 Phase 2, 26 Phase 3, 15 Phase 4.
Follow this condition Literature Review of Inflammatory Bowel Disease trials Research Report on Inflammatory Bowel Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LMT503 First-in-human SAD, MAD, and FE Study LMT503, Placebo - Inflammatory Bowel Disease, Colitis, Ulcerative | Phase 1 | Not yet recruiting | Lmito Therapeutics Inc. | 72 | 2027-03-01 | 2026-09-01 |
| The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares elemental diet (ED) - Inflammatory Bowel Disease | Not applicable | Not yet recruiting | Wake Forest University Health Sciences | 42 | 2026-12-01 | 2026-09-28 |
| Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease Inflammatory Bowel Disease, Crohn's Disease | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 100 | 2026-10-26 | 2026-10-21 | |
| Early Changes in Inflammatory Indices and Healing in IBD Inflammatory Bowel Disease, Ulcerative Colitis | Not yet recruiting | Assiut University | 138 | 2026-09-30 | 2026-10-02 | |
| A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication Mirikizumab - Lactation, Inflammatory Bowel Disease | Phase 4 | Recruiting | Eli Lilly and Company | 14 | 2026-08-05 | 2026-09-08 |
| Impact of Morning Light Therapy in IBD Morning Light Therapy - Inflammatory Bowel Disease | Not applicable | Recruiting | Icahn School of Medicine at Mount Sinai | 30 | 2026-07-01 | 2026-10-09 |
| A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab Inflammatory Bowel Disease, Colitis, Ulcerative | Recruiting | Janssen-Cilag A.G., Switzerland | 50 | 2026-04-13 | 2026-06-12 | |
| Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease MBC-IBD Intervention, Enhanced Treatment as Usual (E-TAU) - Inflammatory Bowel Disease | Not applicable | Recruiting | VA Office of Research and Development | 250 | 2026-03-09 | 2026-03-11 |
| Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors Fecal Microbiota Transplantation (FMT) - Ulcerative Colitis (UC), Inflammatory Bowel Disease | Phase 2 | Recruiting | First Affiliated Hospital of Kunming Medical University | 200 | 2026-02-03 | 2026-09-15 |
| Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients Hospital-Based Vaccination Pathway - Chronic Disease, Immunocompromised | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1500 | 2026-02-01 | 2026-02-05 | |
| Continuous HRV Monitoring for Predicting Response to Biologic Therapy in IBD Inflammatory Bowel Disease, Heart Rate Variability | Enrolling by invitation | Xijing Hospital | 100 | 2025-12-25 | 2026-03-16 | |
| Automated Clinical Pathway for Inflammatory Bowel Disease Care Electronic medical record-based care pathway - Inflammatory Bowel Disease, Inflammatory Bowel Disease (IBD) | Not applicable | Enrolling by invitation | University of Texas Southwestern Medical Center | 1000 | 2025-12-12 | 2025-12-15 |
| A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK) Inflammatory Bowel Disease, Colitis, Ulcerative | Recruiting | Janssen-Cilag Ltd. | 220 | 2025-11-17 | 2026-09-25 | |
| A Clinical Study to Evaluate SM17 in Healthy Participants SM17, SM17 placebo - Atopic Dermatitis, Asthma | Phase 1 | Completed | SinoMab BioScience Ltd | 30 | 2025-10-14 | 2026-04-06 |
| A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany Inflammatory Bowel Disease, Colitis, Ulcerative | Recruiting | Janssen-Cilag G.m.b.H | 500 | 2025-08-18 | 2026-09-25 | |
| Tracking the Natural Course of Silent Small Bowel Narrowing in Adults With Crohn's Disease Inflammatory Bowel Disease | Completed | University Medical Center Zvezdara | 150 | 2025-06-09 | 2025-09-11 | |
| Whey Protein Milk-Derived Exosomes Whey Protein Milk-Derived Exosomes - Ulcerative Colitis, Inflammatory Bowel Disease | Not applicable | Completed | Exosomm Ltd. | 31 | 2025-03-26 | 2026-10-16 |
| Gut Microbiota in IBD With Comorbid Depressive Disorder Not applicable- observational study - Inflammatory Bowel Disease, Depressive Disorder | Recruiting | Fang Tang | 120 | 2025-03-16 | 2026-01-23 | |
| Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease Probiotic - Inflammatory Bowel Disease | Not applicable | Completed | Wecare Probiotics Co., Ltd. | 41 | 2025-01-01 | 2026-10-19 |
| COVID-19 Booster and IIV Schedule in Immunocompromised Hosts Inactivated influenza vaccine (IIV) at baseline, COVID-19 Vaccines at a 3-month interval, Inactivated influenza vaccine at Month 1 - COVID 19, Influenza | Phase 2 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 660 | 2024-11-20 | 2026-03-10 |
Showing 20 of 314. Sign in to see all of them.
Inflammatory Bowel Diseases (314) · Crohn Disease (121) · Colitis, Ulcerative (120) · Irritable Bowel Syndrome (12) · Colitis (11) · Colorectal Neoplasms (11) · Arthritis, Rheumatoid (9) · Anemia, Iron-Deficiency (8) · Anemia (7) · Gastrointestinal Diseases (7) · Intestinal Diseases (7) · Iron Deficiencies (7) · Cholangitis, Sclerosing (6) · Digestive System Diseases (6) · Depression (5)
Gastroenteritis (313) · Digestive System Diseases (308) · Gastrointestinal Diseases (307) · Intestinal Diseases (307) · Colonic Diseases (141) · Colitis (116) · Pathological Conditions, Signs and Symptoms (41) · Pathologic Processes (26) · Immune System Diseases (19) · Nutritional and Metabolic Diseases (18) · Behavior (17) · Neoplasms (17) · Metabolic Diseases (16) · Skin and Connective Tissue Diseases (16) · Hemic and Lymphatic Diseases (15)
Infliximab (7) · Standard of Care (5) · vedolizumab (5) · Blood Specimen Collection (4) · Cholecalciferol (4) · Fecal Microbiota Transplantation (4) · Adalimumab (3) · Azathioprine (3) · Cognitive Behavioral Therapy (3) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (3) · ferric carboxymaltose (3) · ferric maltol (3) · ferric trimaltol (3) · AndoSan (2) · Calorimetry, Indirect (2)
Takeda (6) · Icahn School of Medicine at Mount Sinai (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Tel-Aviv Sourasky Medical Center (5) · Boston Children's Hospital (4) · Indiana University (4) · Johns Hopkins University (4) · Oslo University Hospital (4) · Pharmacosmos A/S (4) · University of Alberta (4) · University of Pittsburgh (4) · Cedars-Sinai Medical Center (3) · Chinese University of Hong Kong (3) · Janssen Research & Development, LLC (3) · Mayo Clinic (3)
United States (119) · Canada (31) · Israel (22) · China (20) · United Kingdom (19) · France (18) · Denmark (15) · Germany (14) · Spain (14) · Netherlands (12) · Belgium (9) · South Korea (9) · Australia (8) · Norway (8) · Poland (8)
Eva Szigethy, MD, PhD (4) · Christa S Zerbe, M.D. (2) · Christian Jakobsen, MD, PhD (2) · Christoph Gasche, Professor (2) · Diana Horta (2) · Florin Selaru, M.D. (2) · Ivan J Fuss, M.D. (2) · James D Lewis, MD, MSCE (2) · Jeanne Tung, MD (2) · Katrine Carlsen, MD (2) · Lee Denson, M.D. (2) · Lene Riis, MD, PhD (2)
PMID 40243391, PMID 27959607, PMID 29142515, PMID 29409871, PMID 29909019, PMID 30739254, PMID 31279870, PMID 32964215, PMID 34077627, PMID 36150926, PMID 37368103, PMID 37391056, PMID 38310565, PMID 42427284, PMID 25545376, PMID 27237709, PMID 33064186, PMID 39109266, PMID 40890737, PMID 10786614, PMID 11773501, PMID 12220494, PMID 12677098, PMID 15050885, PMID 15564816, PMID 16601643, PMID 17222320, PMID 17255260, PMID 17262812, PMID 17885570, PMID 17985376, PMID 18325386, PMID 18338782, PMID 18477354, PMID 18623174, PMID 19208097, PMID 19577749, PMID 20389294, PMID 21047794, PMID 21618351, PMID 21991594, PMID 22456619, PMID 22595313, PMID 22866007, PMID 22941427, PMID 23059643, PMID 23078888, PMID 23188075, PMID 23648372, PMID 23957526
2025 (2), R01DK059961 (2), U01DK062431 (2), 1UL1RR025014-01 (1), 2009 (1), 2014 (1), 2017 (1), K07CA104701 (1), K08CA237619 (1), K23DK076979 (1), P01AI125181 (1), R01DK048351 (1), R01DP000339 (1), R01HD050345 (1), R01HD099344 (1)